Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Interferon-alpha 2b is not effective in the treatment of refractory immune thrombocytopenic purpura

Vol. 83 No. 8 (1998): August, 1998

Abstract

About 25-30% of patients with immune thrombocytopenic purpura (ITP) are refractory to corticosteroids, splenectomy and other treatments. It has been suggested that interferon-alpha 2b (IFN-alpha 2b) may be useful in the treatment of chronic refractory ITP patients. We treated 9 chronic refractory ITP patients with IFN-alpha 2b: the results were poor.

Figures & Tables

Article Information

Vol. 83 No. 8 (1998): August, 1998 : Letters to the Editor
 
 
Published
1998-01-01
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 

Article Usage

Online Views
114
PDF Downloads
72

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2024 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online